Multiomic Market Outlook for 2024 to 2034

The multiomic market is expected to be valued at US$ 3.9 billion in 2024 and rise to US$ 15.3 billion by 2034. The market is predicted to grow at a CAGR of 14.8% during the forecast period. The rising prevalence of chronic disorders and complex health conditions necessitates holistic approach in spurring the market.

Key Market Drivers

With the objective of omics sciences to identify and quantify biological molecules for the upliftment of biological beings, there is a huge rise in the multiomics market. Some factors are mentioned below.

  • High demand for multiomic solutions in pharmaceuticals and biotech sectors for insights into drug discovery and development.
  • Clinical diagnostics is witnessing a surge in multiomic technology adoption for accuracy in disease diagnosis and personalized treatments.
  • Multiomic applications are boosting agri-genomics, facilitating enhanced crop breeding programs and agricultural productivity.
  • Environmental monitoring embraces multiomic aspects to understand ecosystem dynamics and address pollution challenges.
  • Nutrigenomics is leveraging multiomic techniques to develop tailored dietary interventions, resulting in steady growth in the nutrition and wellness sectors.
  • Bioinformatics services catering to multiomic data analysis and interpretation are accelerating growth in the computational biology segment.
  • Startups and niche players specializing in multiomic platforms are diversifying the market landscape and contributing to its expansion.
Attributes Key Statistics
Multiomic Market Value (2024) US$ 3.9 billion
Anticipated Market Value (2034) US$ 15.3 billion
Estimated Growth (2024 to 2034) 14.8% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Diverse Applications of Multiomics Drive its Profitability in Various Fields

Despite the healthy growth of multiomics market with heavy demand in omics sectors, several factors are slowing down the market.

  • Clinical Laboratories are increasingly adopting multiomic analysis, boosting their sales and increasing the accuracy of their diagnoses.
  • Agricultural research institutions and companies are adopting multiomic technologies to meet the uprising need for advanced crop breeding programs and sustainable agriculture practices.
  • Governments and industries are turning to multiomic approaches in environmental monitoring and remediation, seeking more effective solutions for ecosystem management challenges.
  • The need for personalized dietary recommendations based on genetic and metabolic profiles is fueling the demand for multiomics in the nutrition and wellness sector.
  • The computational biology market is seeing increased sales of multiomic data analysis tools, as researchers require advanced algorithms for interpreting complex biological datasets.
  • Academic research institutions are hiking demand for specialized equipment and reagents as they adopt multiomic technologies.
  • Demand for integrated multiomic solutions that offer seamless data integration and analysis capabilities has increased in the biotechnology and life sciences sectors.

Challenges Impeding Growth in the Multiomic Market

  • High costs of equipment, reagents, and data analysis tools, especially in resource-limited settings have pushed the adoption of multiomic technology.
  • Data interpretation and analysis complexity require specialized infrastructure and expertise, hindering the implementation of multiomic approaches.
  • Limited standardization and interoperability of multiomic platforms and data formats may impede the implementation of multiomic approaches.
  • Regulatory uncertainties surrounding the usage of multiomic technologies in clinical settings may hinder market growth due to stringent approval processes.
  • Insufficient awareness and understanding of multiomic approaches among healthcare professionals, researchers, and policymakers may hold back the market.
  • Limited scalability of multiomic technologies may restrict their applicability in large-scale studies or industrial applications, impacting market penetration.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights

Multiomics Services Provide Specialised Expertise and Analysis

Multiomics service providers ensure quality assurance and validation and the segment is expected to expand at a 14.6% CAGR through 2034.

Attributes Details
Top Component Services
CAGR (2024 to 2034) 14.6%
  • Multiomics service providers offer specialized expertise and consultation to interpret complex data and provide tailored solutions to clients.
  • Service providers offer customized multiomic analysis packages that cater to diverse research objectives and industry requirements, enhancing their significance in the global market.
  • Multiomics service providers ensure quality assurance and validation throughout the analysis process, instilling confidence in clients regarding the accuracy and reliability of results.
  • Key companies are providing continuous support and training to clients, aids in efficient utilization of multiomic technologies, and ensures ongoing collaboration and satisfaction.

Precise Cellular Insights and Diverse Applications Paved the way for the Upliftment of Single-Cell Multiomics Technology

Based on the type, the single-cell multiomics segment is projected to grow at a 14.4% CAGR from 2024 to 2034.

Attributes Details
Top Type Single-Cell Multi-Omics
CAGR (2024 to 2034) 14.4%
  • Unparalleled resolution and precision, which allow analysis of cellular heterogeneity at the individual cell level, are offered by single-cell multiomics technologies.
  • Single-cell multiomics technologies provide valuable insights into intricate cellular dynamics and regulatory networks, helping in understanding disease mechanisms, drug responses, and developmental processes.
  • Single-cell multiomics approaches are enabling personalized medicine initiatives by profiling individual cells within heterogeneous tissues, thus facilitating the identification of biomarkers, therapeutic targets, and patient-specific treatment strategies.
  • Expanding research landscape across various disciplines, such as oncology, immunology, neuroscience, and developmental biology, demands high-resolution multiomic analyses at the single-cell level to unravel complex biological processes and disease pathways

Country-wise Insights

The section analyzes the global multiomic market by country, including the United Kingdom, the United States, China, South Korea, and Japan. The table presents the CAGR for each country, indicating the expected market growth through 2034.

Countries CAGR through 2034
South Korea 17.0%
Japan 16.4%
United Kingdom 16.0%
China 15.5%
United States 15.1%

Extensive Network of Medical Institutions and Universal Coverage in South Korea Boost Healthcare Sector

With growing demand for personalized medicine and advancements in precision healthcare, South Korea is well-positioned to capitalize on the opportunities presented by the expanding multiomics market with a projected CAGR of 17.0% from 2024 to 2034.

Strong research infrastructure, government support, and highly skilled workforce pave the way in South Korea’s global multiomics market expansion. Institutions such as the Korean Institute of Science and Technology (KIST), Seoul National University (SNU), and Korea Advanced Institute of Science and Technology (KAIST) have emerged as leaders in multiomics research due to their high-tech facilities and collaborations with major industry partners.

Government support through initiatives like the Bio-Vision 2016 strategy and the Bio-Cluster Development Project has further heightened the growth of the biotech sector in South Korea

Japan's Emphasis on Patient-Centeredness Positions it as a Significant Player in Omics Research

With a robust infrastructure, skilled workforce, and a culture of innovation, Japan is well-positioned to continue its expansion in the multiomics market, with a CAGR of 16.4% through 2034.

Cutting-edge technologies and meticulous research methodologies, and has fostered numerous distinguished research labs and institutions dedicated to multiomics in Japan. Collaborative efforts between academia, industry, and government have propelled Japan's multiomics sector forward, developing advanced analytical platforms such as mass spectrometry and next-generation sequencing technologies.

Japan's multiomics landscape is characterized by a vibrant ecosystem of startups, biotech companies, and research consortia actively contributing to the commercialization and adoption of multiomics technologies.

Key players like Takara Bio, Illumina, and Shimadzu Corporation have leveraged Japan's research capabilities to develop high-throughput platforms for genomic and proteomic analysis, catering to diverse drug discovery, diagnostics, and agricultural biotechnology applications.

Multi-Stakeholder Research System in the United Kingdom Aids the growth of the Multiomic Market

The United Kingdom is upheading the multiomics market with innovative research, advanced bioinformatics tools, and exceptional infrastructure. With a CAGR of 16.0% projected through 2034, it is maintaining a steady pace of growth.

The United Kingdom has made remarkable strides in multiomics research, and its collaboration with biotechnology companies and academic institutions has led to groundbreaking discoveries and commercialization of innovative technologies.

World-class research facilities and supportive policies for the life sciences sector have attracted top talent and investment in the United Kingdom, facilitating the translation of research findings into market-ready products and services. The United Kingdom is driving advancements in personalized medicine, drug discovery, and precision agriculture, enhancing its growth in the global market.

Rapid Growth and Significant Government Investments in China to Accelerate Market Growth

Investments in research foundations and infrastructure to support multiomics research and development, establishing world-class institutions, and collaborating with renowned international partners, China is emerging as a key player in the market. The market in China is expected to rise at a CAGR of 15.5% from 2024 to 2034.

China has a vast population with diverse genetic backgrounds, providing an enormous pool of research subjects for multiomics studies. This has led to the expansion of advanced healthcare solutions tailored for individual genetic profiles.

China has also invested significantly in research foundations and infrastructure to support multiomics research and development, establishing world-class institutions and collaborating with renowned international partners. Ongoing strategic investments, population demand, and a collaborative approach position China as a key player in the global market.

The Multiomic Market in the United States is Evolving With Reputed Biotech Companies

The presence of key players in the biotech and pharma sector fuels investment and fosters partnerships, accelerating the adoption of multiomics solutions in the United States market. Thus, ongoing advancement and research fuel market growth, with an expected CAGR of 15.1%, which is expected to persist until 2034.

The rising demand for advanced healthcare solutions to tackle chronic disorders is an emerging forerunner for the United States market. With a significant burden of chronic diseases such as diabetes, cardiovascular disorders, and cancer, the multiomics approach integrating genomics, proteomics, and metabolomics offers a comprehensive understanding of disease mechanisms and personalized treatment options.

The country's robust ecosystem of research laboratories, medical centers, and biotech companies supports innovation and collaboration in multiomics research and development, leading to the discovery of novel biomarkers and the development of advanced analytical tools.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

The field of omics research is marked by several renowned laboratories, which are known for their groundbreaking contributions. The Broad Institute, the Wellcome Sanger Institute, and the Max Planck Institute for Molecular Genetics are some of the most esteemed institutions in the field, particularly for their pioneering work in genomics, transcriptomics, proteomics, and other related areas.

In addition, Illumina, Thermo Fisher Scientific, and 10x Genomics are pivotal players in the multiomics market are also in row for expansion through their innovative approaches.

These companies are consistently developing advanced sequencing technologies, integrated platforms, and comprehensive analysis software, facilitating the seamless integration of multiomic data. Thus strategic collaborations with other industry leaders such as Qiagen, Agilent Technologies, and BGI Genomics are further enhancing the accessibility, scalability, and reliability of multiomics solutions, which can help market scale upwards.

Recent Developments

  • On February 24, 2024, Vizzhy CEO Dr. Vishnuvardhan unveiled the world's first Multiomics Lab in Bangalore, marking a breakthrough in healthcare innovation. The initiative was announced during the soft launch event of the Vizzhy Multiomics platform, revolutionizing the approach to understanding and treating metabolic disorders.
  • On October 10, 2023, CENTOGENE expanded its Multiomic diagnostic portfolio with the launch of a newly-introduced Transcriptomic offering. The announcement was made in Cambridge, Mass., Rostock, Germany, and Berlin, signifying a significant advancement in life science.
  • On August 29, 2023, BioSkryb Genomics partnered with Research Instruments Pte Ltd to bring industry-leading Single-Cell Technologies to Singapore and Southeast Asia. The strategic distribution agreement expanded access to BioSkryb's best-in-class single-cell multiomics portfolio throughout the region.

Key Companies in the Market

  • Becton
  • Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Danaher
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • BGI Group
  • Becton, Dickinson, and Company
  • Shimadzu Corporation

Key Coverage in the Multiomic Market Report

  • Detailed Study in Applications of Multi-Omics Analysis in Human Diseases
  • Assessment of the Multi-omics data integration tools and methods
  • Multiomics Analysis Software Demand Analysis
  • Market Analysis on Choosing Catheter Materials- Flexible and tough
  • Insights into the Difference Between Single Omics and Multi-Omics
  • Call for Machine Learning Methods for Multi-Omics Data Integration

Market Segmentation

By Component:

  • Instruments
  • Consumables
  • Software
  • Services

By Multiomic Type:

  • Single-Cell Multi-Omics
  • Bulk Multi-Omics

By Platform:

  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms

By Application:

  • Oncology
  • Cell Biology
  • Neurology
  • Immunology
  • Other Applications

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Middle East and Africa (MEA)
  • Europe

Frequently Asked Questions

What is the Multiomic Market Worth in 2024?

The multiomic market is projected to be valued at US$ 3.9 billion in 2024.

What is the Sales Forecast for the Multiomics through 2034?

The multiomic market is expected to reach a valuation of US$ 15.3 billion by 2034.

At What Rate is the Multiomic Market Expected to Grow?

The multiomic market is expected to grow at a CAGR of 14.8% from 2024 to 2034.

What was the Valuation of the Multiomics Market in 2019?

The valuation of the multiomic market was 1.7 billion in 2019.

Who are the Key Manufacturers in the Market?

Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Illumina, Inc., and Danaher are among the major companies actively contributing to the growth of the global multiomic market.

What is the Top Type of Multiomic Research?

Single-cell multiomics is the top type, which is anticipated to grow at a 14.4% CAGR through 2034.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

    4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Component

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Component, 2019 to 2023

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Component, 2024 to 2034

        5.3.1. Instruments

        5.3.2. Consumables

        5.3.3. Software

        5.3.4. Services

    5.4. Y-o-Y Growth Trend Analysis By Component, 2019 to 2023

    5.5. Absolute $ Opportunity Analysis By Component, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2019 to 2023

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2024 to 2034

        6.3.1. Single-Cell Multiomic

        6.3.2. Bulk Multiomic

    6.4. Y-o-Y Growth Trend Analysis By Type, 2019 to 2023

    6.5. Absolute $ Opportunity Analysis By Type, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Platform

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Platform, 2019 to 2023

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Platform, 2024 to 2034

        7.3.1. Genomics

        7.3.2. Transcriptomics

        7.3.3. Proteomics

        7.3.4. Metabolomics

        7.3.5. Integrated Omics Platforms

    7.4. Y-o-Y Growth Trend Analysis By Platform, 2019 to 2023

    7.5. Absolute $ Opportunity Analysis By Platform, 2024 to 2034

8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034

        8.3.1. Oncology

        8.3.2. Cell Biology

        8.3.3. Neurology

        8.3.4. Immunology

        8.3.5. Other Applications

    8.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023

    8.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034

9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User

    9.1. Introduction / Key Findings

    9.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2019 to 2023

    9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2024 to 2034

        9.3.1. Academic and Research Organizations

        9.3.2. Pharmaceutical & Biotechnology Companies

        9.3.3. Hospital and Diagnostic Laboratories

        9.3.4. Other End-Users

    9.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023

    9.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034

10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

    10.1. Introduction

    10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023

    10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Western Europe

        10.3.4. Eastern Europe

        10.3.5. South Asia and Pacific

        10.3.6. East Asia

        10.3.7. Middle East and Africa

    10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        11.2.1. By Country

            11.2.1.1. USA

            11.2.1.2. Canada

        11.2.2. By Component

        11.2.3. By Type

        11.2.4. By Platform

        11.2.5. By Application

        11.2.6. By End-User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Component

        11.3.3. By Type

        11.3.4. By Platform

        11.3.5. By Application

        11.3.6. By End-User

    11.4. Key Takeaways

12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        12.2.1. By Country

            12.2.1.1. Brazil

            12.2.1.2. Mexico

            12.2.1.3. Rest of Latin America

        12.2.2. By Component

        12.2.3. By Type

        12.2.4. By Platform

        12.2.5. By Application

        12.2.6. By End-User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Component

        12.3.3. By Type

        12.3.4. By Platform

        12.3.5. By Application

        12.3.6. By End-User

    12.4. Key Takeaways

13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        13.2.1. By Country

            13.2.1.1. Germany

            13.2.1.2. UK

            13.2.1.3. France

            13.2.1.4. Spain

            13.2.1.5. Italy

            13.2.1.6. Rest of Western Europe

        13.2.2. By Component

        13.2.3. By Type

        13.2.4. By Platform

        13.2.5. By Application

        13.2.6. By End-User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Component

        13.3.3. By Type

        13.3.4. By Platform

        13.3.5. By Application

        13.3.6. By End-User

    13.4. Key Takeaways

14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        14.2.1. By Country

            14.2.1.1. Poland

            14.2.1.2. Russia

            14.2.1.3. Czech Republic

            14.2.1.4. Romania

            14.2.1.5. Rest of Eastern Europe

        14.2.2. By Component

        14.2.3. By Type

        14.2.4. By Platform

        14.2.5. By Application

        14.2.6. By End-User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Component

        14.3.3. By Type

        14.3.4. By Platform

        14.3.5. By Application

        14.3.6. By End-User

    14.4. Key Takeaways

15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        15.2.1. By Country

            15.2.1.1. India

            15.2.1.2. Bangladesh

            15.2.1.3. Australia

            15.2.1.4. New Zealand

            15.2.1.5. Rest of South Asia and Pacific

        15.2.2. By Component

        15.2.3. By Type

        15.2.4. By Platform

        15.2.5. By Application

        15.2.6. By End-User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Component

        15.3.3. By Type

        15.3.4. By Platform

        15.3.5. By Application

        15.3.6. By End-User

    15.4. Key Takeaways

16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        16.2.1. By Country

            16.2.1.1. China

            16.2.1.2. Japan

            16.2.1.3. South Korea

        16.2.2. By Component

        16.2.3. By Type

        16.2.4. By Platform

        16.2.5. By Application

        16.2.6. By End-User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Component

        16.3.3. By Type

        16.3.4. By Platform

        16.3.5. By Application

        16.3.6. By End-User

    16.4. Key Takeaways

17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

    17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023

    17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034

        17.2.1. By Country

            17.2.1.1. GCC Countries

            17.2.1.2. South Africa

            17.2.1.3. Israel

            17.2.1.4. Rest of MEA

        17.2.2. By Component

        17.2.3. By Type

        17.2.4. By Platform

        17.2.5. By Application

        17.2.6. By End-User

    17.3. Market Attractiveness Analysis

        17.3.1. By Country

        17.3.2. By Component

        17.3.3. By Type

        17.3.4. By Platform

        17.3.5. By Application

        17.3.6. By End-User

    17.4. Key Takeaways

18. Key Countries Market Analysis

    18.1. USA

        18.1.1. Market Share Analysis, 2023

            18.1.1.1. By Component

            18.1.1.2. By Type

            18.1.1.3. By Platform

            18.1.1.4. By Application

            18.1.1.5. By End-User

    18.2. Canada

        18.2.1. Market Share Analysis, 2023

            18.2.1.1. By Component

            18.2.1.2. By Type

            18.2.1.3. By Platform

            18.2.1.4. By Application

            18.2.1.5. By End-User

    18.3. Brazil

        18.3.1. Market Share Analysis, 2023

            18.3.1.1. By Component

            18.3.1.2. By Type

            18.3.1.3. By Platform

            18.3.1.4. By Application

            18.3.1.5. By End-User

    18.4. Mexico

        18.4.1. Market Share Analysis, 2023

            18.4.1.1. By Component

            18.4.1.2. By Type

            18.4.1.3. By Platform

            18.4.1.4. By Application

            18.4.1.5. By End-User

    18.5. Germany

        18.5.1. Market Share Analysis, 2023

            18.5.1.1. By Component

            18.5.1.2. By Type

            18.5.1.3. By Platform

            18.5.1.4. By Application

            18.5.1.5. By End-User

    18.6. UK

        18.6.1. Market Share Analysis, 2023

            18.6.1.1. By Component

            18.6.1.2. By Type

            18.6.1.3. By Platform

            18.6.1.4. By Application

            18.6.1.5. By End-User

    18.7. France

        18.7.1. Market Share Analysis, 2023

            18.7.1.1. By Component

            18.7.1.2. By Type

            18.7.1.3. By Platform

            18.7.1.4. By Application

            18.7.1.5. By End-User

    18.8. Spain

        18.8.1. Market Share Analysis, 2023

            18.8.1.1. By Component

            18.8.1.2. By Type

            18.8.1.3. By Platform

            18.8.1.4. By Application

            18.8.1.5. By End-User

    18.9. Italy

        18.9.1. Market Share Analysis, 2023

            18.9.1.1. By Component

            18.9.1.2. By Type

            18.9.1.3. By Platform

            18.9.1.4. By Application

            18.9.1.5. By End-User

    18.10. Poland

        18.10.1. Market Share Analysis, 2023

            18.10.1.1. By Component

            18.10.1.2. By Type

            18.10.1.3. By Platform

            18.10.1.4. By Application

            18.10.1.5. By End-User

    18.11. Russia

        18.11.1. Market Share Analysis, 2023

            18.11.1.1. By Component

            18.11.1.2. By Type

            18.11.1.3. By Platform

            18.11.1.4. By Application

            18.11.1.5. By End-User

    18.12. Czech Republic

        18.12.1. Market Share Analysis, 2023

            18.12.1.1. By Component

            18.12.1.2. By Type

            18.12.1.3. By Platform

            18.12.1.4. By Application

            18.12.1.5. By End-User

    18.13. Romania

        18.13.1. Market Share Analysis, 2023

            18.13.1.1. By Component

            18.13.1.2. By Type

            18.13.1.3. By Platform

            18.13.1.4. By Application

            18.13.1.5. By End-User

    18.14. India

        18.14.1. Market Share Analysis, 2023

            18.14.1.1. By Component

            18.14.1.2. By Type

            18.14.1.3. By Platform

            18.14.1.4. By Application

            18.14.1.5. By End-User

    18.15. Bangladesh

        18.15.1. Market Share Analysis, 2023

            18.15.1.1. By Component

            18.15.1.2. By Type

            18.15.1.3. By Platform

            18.15.1.4. By Application

            18.15.1.5. By End-User

    18.16. Australia

        18.16.1. Market Share Analysis, 2023

            18.16.1.1. By Component

            18.16.1.2. By Type

            18.16.1.3. By Platform

            18.16.1.4. By Application

            18.16.1.5. By End-User

    18.17. New Zealand

        18.17.1. Market Share Analysis, 2023

            18.17.1.1. By Component

            18.17.1.2. By Type

            18.17.1.3. By Platform

            18.17.1.4. By Application

            18.17.1.5. By End-User

    18.18. China

        18.18.1. Market Share Analysis, 2023

            18.18.1.1. By Component

            18.18.1.2. By Type

            18.18.1.3. By Platform

            18.18.1.4. By Application

            18.18.1.5. By End-User

    18.19. Japan

        18.19.1. Market Share Analysis, 2023

            18.19.1.1. By Component

            18.19.1.2. By Type

            18.19.1.3. By Platform

            18.19.1.4. By Application

            18.19.1.5. By End-User

    18.20. South Korea

        18.20.1. Market Share Analysis, 2023

            18.20.1.1. By Component

            18.20.1.2. By Type

            18.20.1.3. By Platform

            18.20.1.4. By Application

            18.20.1.5. By End-User

    18.21. GCC Countries

        18.21.1. Market Share Analysis, 2023

            18.21.1.1. By Component

            18.21.1.2. By Type

            18.21.1.3. By Platform

            18.21.1.4. By Application

            18.21.1.5. By End-User

    18.22. South Africa

        18.22.1. Market Share Analysis, 2023

            18.22.1.1. By Component

            18.22.1.2. By Type

            18.22.1.3. By Platform

            18.22.1.4. By Application

            18.22.1.5. By End-User

    18.23. Israel

        18.23.1. Market Share Analysis, 2023

            18.23.1.1. By Component

            18.23.1.2. By Type

            18.23.1.3. By Platform

            18.23.1.4. By Application

            18.23.1.5. By End-User

19. Market Structure Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Market Share Analysis of Top Players

        19.3.1. By Regional

        19.3.2. By Component

        19.3.3. By Type

        19.3.4. By Platform

        19.3.5. By Application

        19.3.6. By End-User

20. Competition Analysis

    20.1. Competition Deep Dive

        20.1.1. Becton, Dickinson and Company

            20.1.1.1. Overview

            20.1.1.2. Product Portfolio

            20.1.1.3. Profitability by Market Segments

            20.1.1.4. Sales Footprint

            20.1.1.5. Strategy Overview

                20.1.1.5.1. Marketing Strategy

        20.1.2. Thermo Fisher Scientific Inc.

            20.1.2.1. Overview

            20.1.2.2. Product Portfolio

            20.1.2.3. Profitability by Market Segments

            20.1.2.4. Sales Footprint

            20.1.2.5. Strategy Overview

                20.1.2.5.1. Marketing Strategy

        20.1.3. Illumina, Inc

            20.1.3.1. Overview

            20.1.3.2. Product Portfolio

            20.1.3.3. Profitability by Market Segments

            20.1.3.4. Sales Footprint

            20.1.3.5. Strategy Overview

                20.1.3.5.1. Marketing Strategy

        20.1.4. Danaher

            20.1.4.1. Overview

            20.1.4.2. Product Portfolio

            20.1.4.3. Profitability by Market Segments

            20.1.4.4. Sales Footprint

            20.1.4.5. Strategy Overview

                20.1.4.5.1. Marketing Strategy

        20.1.5. PerkinElmer Inc.

            20.1.5.1. Overview

            20.1.5.2. Product Portfolio

            20.1.5.3. Profitability by Market Segments

            20.1.5.4. Sales Footprint

            20.1.5.5. Strategy Overview

                20.1.5.5.1. Marketing Strategy

        20.1.6. Shimadzu Corporation

            20.1.6.1. Overview

            20.1.6.2. Product Portfolio

            20.1.6.3. Profitability by Market Segments

            20.1.6.4. Sales Footprint

            20.1.6.5. Strategy Overview

                20.1.6.5.1. Marketing Strategy

        20.1.7. Bruker

            20.1.7.1. Overview

            20.1.7.2. Product Portfolio

            20.1.7.3. Profitability by Market Segments

            20.1.7.4. Sales Footprint

            20.1.7.5. Strategy Overview

                20.1.7.5.1. Marketing Strategy

        20.1.8. QIAGEN

            20.1.8.1. Overview

            20.1.8.2. Product Portfolio

            20.1.8.3. Profitability by Market Segments

            20.1.8.4. Sales Footprint

            20.1.8.5. Strategy Overview

                20.1.8.5.1. Marketing Strategy

        20.1.9. Agilent Technologies, Inc.

            20.1.9.1. Overview

            20.1.9.2. Product Portfolio

            20.1.9.3. Profitability by Market Segments

            20.1.9.4. Sales Footprint

            20.1.9.5. Strategy Overview

                20.1.9.5.1. Marketing Strategy

        20.1.10. CYTENA GmbH

            20.1.10.1. Overview

            20.1.10.2. Product Portfolio

            20.1.10.3. Profitability by Market Segments

            20.1.10.4. Sales Footprint

            20.1.10.5. Strategy Overview

                20.1.10.5.1. Marketing Strategy

        20.1.11. 10x Genomics

            20.1.11.1. Overview

            20.1.11.2. Product Portfolio

            20.1.11.3. Profitability by Market Segments

            20.1.11.4. Sales Footprint

            20.1.11.5. Strategy Overview

                20.1.11.5.1. Marketing Strategy

21. Assumptions & Acronyms Used

22. Research Methodology

Recommendations

Healthcare

Genome Editing Market

February 2024

REP-GB-19118

300 pages

Healthcare

Proteomics Market

October 2022

REP-GB-1170

296 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Multiomic Market

Schedule a Call